ӰƵ

Skip to main content

biomedical engineering

NeuroRadVision-research-team-final
NeuroRadVision, a new technology in brain tumor treatment management, chosen to present to potential investors at Ohio Collegiate Venture Showcase
A team of biomedical engineers at ӰƵ is among seven of 23 research teams from the 2016 I-Corps@Ohio program selected to present to potential investors at the upcoming Ohio Collegiate Venture Showcase. The team will present its new technology in brain tumor treatment…
mri-scan-feat
Computer program beats physicians at brain cancer diagnoses
ӰƵ-led research could speed identification of recurrent tumors, eliminate costly and risky brain biopsies Computer programs have defeated humans in Jeopardy!, chess and Go. Now a program developed at ӰƵ has outperformed physicians on a more…
kilgoreandbhadra
CWRU and Halyard Health partnering to advance non-narcotic pain management
What if eliminating physical pain was a matter of flipping a switch to block it? No drug needed. When it’s time to stop the block, just turn it off. Researchers at ӰƵ hope to eventually treat chronic or acute pain by using energy-based neuromodulation technology. The…
Anant-Madabhushi
Biomedical engineering’s Anant Madabhushi, team awarded three new patents in digital pathology, precision medicine
Anant Madabhushi, the F. Alex Nason professor II of biomedical engineering and director of the Center for Computational Imaging and Personalized Diagnostics (CCIPD), and his team were issued three patents in digital pathology and precision medicine. U.S. patent 9,424,460 titled "Tumor plus…
hartwell
Biomedical engineering postdoctoral researcher awarded Hartwell Fellowship for pediatric cancer research
Jon Whitney, a postdoctoral research associate in the Center for Computational Imaging and Personalized Diagnostics in Case School of Engineering’s Department of Biomedical Engineering, has been named by ӰƵ as a 2015 Hartwell Foundation Fellow. He was recognized for his…
Anant-Madabhushi
Changes in benign tissue next to prostate tumors may predict biochemical recurrence of cancer, scientists find
Changes in benign tissues next to prostate tumors may provide an early warning for patients at higher risk for biochemical recurrence after a radical prostatectomy, a study by researchers at ӰƵ and Johns Hopkins Medical Institutions shows. Biochemical recurrence, which…
Nicole-Steinmetz
Drug candidate shrinks tumor when delivered by plant virus nanoparticle
Phenanthriplatin outperformed cisplatin in mouse model of triple-negative breast cancer when encapsulated into nanocarrier In a pair of firsts, researchers at ӰƵ and Massachusetts Institute of Technology have shown that the drug candidate phenanthriplatin can be more…
cancer-cells
Researchers developing quick, inexpensive test to assess ER+ breast cancers
National Cancer Institute awards $3.3 million to develop digital image analytics Researchers from ӰƵ are teaming with industry and other academics to develop a quick and inexpensive test to predict which women with ER+ breast cancer need chemotherapy and which need…
satish-viswanath
Cleveland researchers developing GPS for rectal cancer surgery
Risk score would determine who would benefit from chemoradiation alone Researchers estimate that, in the United States annually, up to 10,000 rectal cancer patients undergo unnecessary surgery, and more than 25,000 suffer from pelvic sepsis, wound infection and permanent impairments from…
Biomedical engineering’s Anant Madabushi awarded patent, grant
Anant Madabhushi, professor of biomedical engineering and director of the Center for Computational Imaging and Personalized Diagnostics, was recently awarded U.S. patent 9,292,933, titled “Method and apparatus for shape based deformable segmentation of multiple overlapping objects.” The present…